 | Up a level |
Journal Article
Drilon, Alexander, Siena, Salvatore, Dziadziuszko, Rafal 
ORCID: 0000-0001-8080-9843, Barlesi, Fabrice, Krebs, Matthew G., Shaw, Alice T., de Braud, Filippo, Rolfo, Christian, Ahn, Myung-Ju, Wolf, Juergen, Seto, Takashi, Cho, Byoung Chul, Patel, Manish R., Chiu, Chao-Hua, John, Thomas, Goto, Koichi, Karapetis, Christos S., Arkenau, Hendrick-Tobias, Kim, Sang-We, Ohe, Yuichiro, Li, Yu-Chung, Chae, Young K., Chung, Christine H., Otterson, Gregory A., Murakami, Haruyasu, Lin, Chia-Chi, Tan, Daniel S. W., Prenen, Hans, Riehl, Todd, Chow-Maneval, Edna, Simmons, Brian, Cui, Na, Johnson, Ann, Eng, Susan, Wilson, Timothy R. and Doebele, Robert C.
(2020).
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials.
Lancet Oncol., 21 (2).
S. 261 - 271.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-5488
Gautschi, Oliver, Wolf, Juergen, Milia, Julie, Filleron, Thomas, Carbone, David Paul, Camidge, D. Ross, Shih, Jin-Yuan, Awad, Mark M., Cabillic, Florian ORCID: 0000-0001-7204-5652, Peled, Nir, Van Den Heuvel, Michel, Owen, Dwight Hall, Kris, Mark G., Janne, Pasi A., Besse, Benjamin ORCID: 0000-0001-5090-8189, Cho, Byoung Chul, Karp, Daniel D., Rosell, Rafael, Mazieres, Julien and Drilon, Alexander E.
(2016).
Targeting RET in patients with RET-rearranged lung cancers: Results from a global registry.
J. Clin. Oncol., 34 (15).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755